ocrelizumab,fingolimod
roche,novartis
['ocrelizumab']
after preliminary data suggested that humoral response may be delayed among those vaccinated against #covid19 treated with ocrelizumab, new data from #ectrims suggest a third booster dose can revive such response safely. 
Managing editor, @Neurology_Live ??  host #MindMoments podcast ?? host @medicalwrldnews Deep Dive ?? ??:mhoffman(at)neurologylive(dot)com